Tech Company Financing Transactions
Sense Biodetection Funding Round
Sense Biodetection, based in Milford, scored $15 million from Koch Disruptive Technologies and private investors.
Transaction Overview
Company Name
Announced On
11/18/2021
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Investors
Koch Disruptive Technologies (Lead Investor) (Brett Chugg)
Proceeds Purpose
Funds from the round will be used to support the anticipated U.S. and European commercial launch of Sense's COVID-19 Test on the company's Veros instrument-free molecular platform.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
115 Cedar St. N-3
Milford, MA 01757
USA
Milford, MA 01757
USA
Phone
Undisclosed
Website
Email Address
Overview
At Sense, we believe that if you can test anywhere*, you can change everything. We're focused on creating unconstrained, instrument-free molecular diagnostic technologies that allow caregivers to open the care pathway to everyone -- in a way that's nothing short of revolutionary.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Timothy Still
Chief Financial Officer
Simon Turner
Chief Operating Officer
Ralph Lamble
VP - Bus. Development
Harry Lamble
VP - Bus. Development
Ryan Roberts
Browse more venture capital transactions:
Prev: 11/18/2021: PayZen venture capital transaction
Next: 11/18/2021: aptihealth venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs